Global commercialization partner for biotech therapies in international markets
Medison Pharma acts as an outsourced commercial, medical and operational arm for biotech companies launching therapies outside their home markets, with a focus on rare and severe diseases. A sales- and medical-heavy hiring mix across Central and Eastern Europe, Greece, South Korea and Brazil, plus a Veeva CRM, Salesforce and NetSuite core paired with Anaplan, Jedox and IBM Planning Analytics, points to a field-driven launch engine with layered financial planning.
Notable leadership hires: Business Unit Head, Director Indirect Procurement & Facilities, ERP Lead, Medical Head, Partner Integration Lead
Medison Pharma is a privately held company founded in 1996 and headquartered in Petach Tikva, Israel, with 501–1,000 employees. It partners with biotech developers to bring specialty and rare-disease therapies to patients in international markets, running local commercial, medical and operational functions on their behalf. Current hiring spans Hungary, Romania, Estonia, Poland, Slovenia, Greece, Germany, South Korea, Brazil and Israel. Open leadership roles include a Business Unit Head, Medical Head, ERP Lead and Partner Integration Lead.
Medison Pharma uses Veeva and Veeva CRM, Salesforce, NetSuite, Anaplan, IBM Planning Analytics, Jedox, Qlik Sense, and a data layer built on AWS, Snowflake and dbt.
Medison Pharma is hiring in Hungary, Romania, Estonia, Israel, Poland, South Korea, Slovenia, Greece, Brazil and Germany, with sales and healthcare roles leading the mix.
Medison Pharma is headquartered in Petach Tikva, Israel. It was founded in 1996 and employs 501–1,000 people.
Other companies in the same industry, closest in size
Medison Pharma's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.